Literature DB >> 1644496

Sequential therapy with ofloxacin in complicated urinary tract infections: a randomized comparative study with ciprofloxacin.

H J Peters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1644496     DOI： 10.1007/bf01704616

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  11 in total

1.  Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections.

Authors:  C E Cox
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

2.  Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients.

Authors:  Y Mouton; O Leroy; C Beuscart; B Sivery; E Senneville; C Chidiac; G Beaucaire; M Vincent du Laurier
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

3.  Pharmacokinetics of ofloxacin after parenteral and oral administration.

Authors:  H Lode; G Höffken; P Olschewski; B Sievers; A Kirch; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

4.  Ofloxacin in urinary tract infections.

Authors:  B Kromann-Andersen; K Krøyer Nielsen
Journal:  Scand J Infect Dis Suppl       Date:  1990

Review 5.  Overview of clinical experience with ciprofloxacin.

Authors:  A P Ball
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

6.  Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.

Authors:  E J Goldstein; R M Kahn; M L Alpert; B P Ginsberg; F L Greenway; D M Citron
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

7.  Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.

Authors:  H Lode; G Höffken; P Olschewski; B Sievers; A Kirch; K Borner; P Koeppe
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

8.  Severe infections treated with intravenous ofloxacin: a prospective clinical multicentre Swiss study.

Authors:  C Regamey; C Steinbach-Lebbin
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

9.  Ofloxacin in the management of complicated urinary tract infections, including prostatitis.

Authors:  C E Cox
Journal:  Am J Med       Date:  1989-12-29       Impact factor: 4.965

Review 10.  Pharmacokinetic disposition of quinolones in human body fluids and tissues.

Authors:  F Sörgel; U Jaehde; K Naber; U Stephan
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447
View more
  3 in total

Review 1.  Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.

Authors:  Florian M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 2.  Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.

Authors:  S V Onrust; H M Lamb; J A Balfour
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 3.  Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.

Authors:  Culley Carson; Kurt G Naber
Journal:  Drugs       Date:  2004       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.